Is secreted interleukin 1 necessary for T cell activation?
Goeken, N.E.; Staggs, T.S.
Transplantation Proceedings 19(1 Part 1): 313-315
1987
ISSN/ISBN: 0041-1345 PMID: 3274779 Document Number: 292147
Document emailed within 1 workday
Related Documents
Amoli, M.M.; Miranda-Filloy, J.A.; Vazquez-Rodriguez, T.R.; Ollier, W.E.R.; Gonzalez-Gay, M.A. 2009: Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum Clinical and Experimental Rheumatology 27(1 Suppl 52: S142-S143Kennedy, M.; Wassmer, P.; Erb, P. 1987: A novel role for interleukin 2 in antibody responses: down-regulation of T helper cell activation Journal of Immunology 139(1): 110-113
Kubota, S.; Siomi, H.; Hatanaka, M.; Pomerantz, R.J. 1996: Cis/trans-activation of the interleukin-9 receptor gene in an HTLV-I-transformed human lymphocytic cell Oncogene 12(7): 1441-1447
Duclos, B.; Reimund, J.M.; Lang, J.M.; Coumaros, G.; Chamouard, P.; Lehr, L.; Baumann, R.; Koehl, C.; Weill, J.P. 1990: Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors Gastroenterologie Clinique et Biologique 14(1): 22-27
Lasfar, A.; Amirand, C.; Ballini, J.P.; Kolb, J.P. 1993: Activation pathways triggered by interleukin-4 in the human plasmacytoma cell line RPMI-8226--differences with resting B lymphocytes European Cytokine Network 4(3): 213-221
Wiskocil, R.; Weiss, A.; Imboden, J.; Kamin-Lewis, R.; Stobo, J. 1985: Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes Journal of Immunology 134(3): 1599-1603
Francis, M.L.; Moss, J.; Fitz, T.A.; Mond, J.J. 1990: CAMP-independent effects of cholera toxin on B cell activation. I. a possible role for cell surface ganglioside GM1 in B cell activation Journal of Immunology 145(10): 3162-3169
Pimentel-Muiños, F.X.; Muñoz-Fernández, M.A.; Fresno, M. 1994: Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines Journal of Immunology 152(12): 5714-5722
Fattorossi, A.; Matricardi, P.M.; Pizzolo, J.G.; Le Moli, S.; Antonelli, G.; D'Amelio, R. 1991: Lack of specificity in the mechanisms involved in the enhancement of the concanavalin A driven human T lymphocyte stimulation by beta-endorphin: studies on activation marker expression, cell cycle and interleukin release Journal of Biological Regulators and Homeostatic Agents 5(3): 91-97
Lissoni, P.; Rovelli, F.; Baiocco, N.; Tangini, G.; Fumagalli, L. 2001: A phase Ii study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone Anticancer Research 21(1b): 777-779
Hobbs, M.V.; Morgan, E.L.; Weigle, W.O. 1985: Synthetic Fc peptide-mediated regulation of the immune response. II. Analysis of secreted immunoglobulin classes, accessory cell contribution, and lymphocyte proliferation in p23-stimulated spleen cell cultures Journal of Immunology 134(5): 2847-2852
Takii, T.; Hayashi, H.; Marunouchi, T.; Onozaki, K. 1994: Interleukin-1 down-regulates type I interleukin 1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence of prostaglandin E2 synthesis Lymphokine and Cytokine Research 13(3): 213-219
Shi, B.; Nakazawa, H.; Ryoji, O.; Goya, N.; Ito, F.; Koga, S.; Okuda, H.; Kobayashi, H.; Toma, H. 1998: Study on urinary levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in patients with renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 44(3): 143-147
Okano, A.; Suzuki, C.; Takatsuki, F.; Akiyama, Y.; Koike, K.; Ozawa, K.; Hirano, T.; Kishimoto, T.; Nakahata, T.; Asano, S. 1989: In vitro expansion of the murine pluripotent hemopoietic stem cell population in response to interleukin 3 and interleukin 6. Application to bone marrow transplantation Transplantation 48(3): 495-498
Chen, Z.; Colon, I.; Ortiz, N.; Callister, M.; Dong, G.; Pegram, M.Y.; Arosarena, O.; Strome, S.; Nicholson, J.C.; Van Waes, C. 1998: Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines Cancer Research 58(16): 3668-3676
Indrová, M.; Jandlová, T.; Bubeník, J. 1992: Interaction of interleukin 2 and interleukin 4 during LAK cell generation Folia Biologica 38(1): 1-9
Macchia, G.; Baldari, C.T.; Massone, A.; Donati, D.; Parente, L.; Telford, J.L. 1990: Activation of gene expression by interleukin 1 Progress in Clinical and Biological Research 349: 329-341
Chirmule, N.; Kalyanaraman, V.S.; Lederman, S.; Oyaizu, N.; Yagura, H.; Yellin, M.J.; Chess, L.; Pahwa, S. 1993: HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6 Journal of Immunology 150(6): 2478-2486
Ford-Hutchinson, A.W. 1992: Activation of leukotriene production in granulocytes: effects on cell activation Immunology Series 57: 87-106
Wu, S.; Rodabaugh, K.; Martinez-Maza, O.; Watson, J.M.; Silberstein, D.S.; Boyer, C.M.; Peters, W.P.; Weinberg, J.B.; Berek, J.S.; Bast, R.C. 1992: Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha American Journal of Obstetrics and Gynecology 166(3): 997-1007